Abstract 7926: Efficacy, in vivo safety, and PK/PD studies for novel, oral, highly selective PTPN2/1 inhibitor (ZE00-0388)
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Molsoft (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148680002
Cites:
Cited by:
Related to: